SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-10-000240
Filing Date
2010-02-16
Accepted
2010-02-16 17:21:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 16, 2010 kvpharmaceutical13ga-021610.htm SC 13G/A 64508
  Complete submission text file 0001013594-10-000240.txt   66281
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 10609845
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 5TH AVE NEW YORK NY 10176
Business Address 551 FIFTH AVENUE NEW YORK NY 10176 2129866000
KLEINBERG KAPLAN WOLFF & COHEN P C (Filed by) CIK: 0001013594 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A